Vaxcyte logo

Vaxcyte Share Price (NASDAQ: PCVX)

$30.25

Live

Last updated on

Check the interactive Vaxcyte Stock chart to analyse performance

Vaxcyte stock performance

as on August 28, 2025 at 12:37 am IST

  • Today's Low:$29.93
    Today's High:$30.90

    Day's Volatility :3.14%

  • 52 Weeks Low:$27.66
    52 Weeks High:$121.06

    52 Weeks Volatility :77.15%

Vaxcyte Stock Returns

PeriodVaxcyte IncSector (Health Care)Index (Russel 2000)
3 Months
-3.6%
3.7%
0.0%
6 Months
-61.54%
-6.9%
0.0%
1 Year
-61.6%
-11.9%
0.0%
3 Years
8.42%
7.7%
-6.9%

Vaxcyte Inc Key Stats

Check Vaxcyte key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$30.25
Open
$30.47
Today's High
$30.9
Today's Low
$29.93
Market Capitalization
$4.2B
Today's Volume
$1.9M
52 Week High
$121.055
52 Week Low
$27.66
Revenue TTM
$0.0
EBITDA
$-698.6M
Earnings Per Share (EPS)
$-4.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-21.65%

Stock Returns calculator for Vaxcyte Stock including INR - Dollar returns

The Vaxcyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vaxcyte investment value today

Current value as on today

₹43,071

Returns

₹56,929

(-56.93%)

Returns from Vaxcyte Stock

₹61,602 (-61.6%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Vaxcyte Stock

-15%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Vaxcyte Stock from India on INDmoney has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vaxcyte Inc

  • Name

    Holdings %

  • HHG PLC

    11.32%

  • FMR Inc

    9.64%

  • Vanguard Group Inc

    9.24%

  • RA Capital Management, LLC

    9.22%

  • BlackRock Inc

    8.15%

  • T. Rowe Price Investment Management,Inc.

    4.62%

Analyst Recommendation on Vaxcyte Stock

Rating
Trend

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Vaxcyte(by analysts ranked 0 to 5 stars)

Vaxcyte Share Price Target

What analysts predicted

Upside of 279.75%

Target:

$114.88

Current:

$30.25

Vaxcyte share price target is $114.88, a slight Upside of 279.75% compared to current price of $30.25 as per analysts' prediction.

Vaxcyte Stock Insights

  • Price Movement

    In the last 7 days, PCVX stock has moved down by -3.2%
  • PCVX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 122.6%
  • PCVX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 105.1%

Vaxcyte Technicals Summary

Sell

Neutral

Buy

Vaxcyte is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Vaxcyte Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Vaxcyte Inc logo
-15.67%
-61.54%
-61.6%
8.42%
43.3%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.9%
-51.12%
-0.89%
-2.51%
Beone Medicines Ltd logo
4.54%
18.87%
52.28%
84.02%
26.72%
Vertex Pharmaceuticals Incorporated logo
-16.02%
-19.22%
-19.42%
37.43%
43.36%
Alnylam Pharmaceuticals, Inc. logo
38.9%
84.99%
60.96%
115.82%
243.29%

Vaxcyte Dividend announcements

  • Vaxcyte Earnings

    Vaxcyte’s price-to-earnings ratio stands at None

About Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Organization
Vaxcyte
Employees
414
CEO
Mr. Grant E. Pickering M.B.A.
Industry
Health Technology

Key Management of Vaxcyte Inc

NameTitle
Mr. Grant E. Pickering M.B.A.
Co-Founder, CEO & Director
Mr. Andrew L. Guggenhime M.B.A.
President & CFO
Mr. James Wassil M.B.A., M.S.
Executive VP & COO
Mr. Mikhail Eydelman J.D.
Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Jeff Fairman Ph.D.
Co-Founder & VP of Research
Ms. Whitney Jones
Chief People Officer
Ms. Janet Graesser
Senior Vice President of Corporate Affairs
Mr. Harp Dhaliwal M.B.A.
Chief Technical Operations Officer
Sam Iki
Senior Vice President of Project Management
Ms. Elvia Cowan
Senior Vice President of Finance

Important FAQs about investing in PCVX Stock from India :

What is Vaxcyte share price today?

Vaxcyte share price today is $30.25 as on . Vaxcyte share today touched a day high of $30.90 and a low of $29.93.

What is the 52 week high and 52 week low for Vaxcyte share?

Vaxcyte share touched a 52 week high of $121.06 and a 52 week low of $27.66. Vaxcyte stock price today i.e. is trending at $30.25, lower by 75.01% versus the 52 week high.

How to invest in Vaxcyte Stock (PCVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vaxcyte on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vaxcyte Shares that will get you 0.0496 shares as per Vaxcyte share price of $30.25 per share as on August 28, 2025 at 12:37 am IST.

What is the minimum amount required to buy Vaxcyte Stock (PCVX) from India?

Indian investors can start investing in Vaxcyte (PCVX) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Vaxcyte stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Vaxcyte share’s latest price of $30.25 as on August 28, 2025 at 12:37 am IST, you will get 0.3306 shares of Vaxcyte. Learn more about fractional shares .

What are the returns that Vaxcyte has given to Indian investors in the last 5 years?

Vaxcyte stock has given 43.3% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?